ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209

被引：25

作者：

Foster, G. R. ^{[1
]}

Hezode, C. ^{[2
]}

Bronowicki, J. -P. ^{[3
]}

Carosi, G. ^{[4
]}

Weiland, O. ^{[5
]}

Verlinden, L. ^{[6
]}

van Heeswijk, R. ^{[6
]}

Vangeneugden, T. ^{[6
]}

Picchio, G. ^{[7
]}

Beumont-Mauviel, M. ^{[6
]}

机构：

[1] Barts & London Queen Marys Sch Med & Dent, Inst Cellular & Mol Sci, London, England

[2] Univ Paris 12, Hop Henri Mondor, AP HP, F-94010 Creteil, France

[3] Ctr Hosp Univ Nancy, Vandoeuvre Les Nancy, France

[4] Univ Brescia, Clin Infect & Trop Dis, Brescia, Italy

[5] Karolinska Univ Hosp Huddinge, Stockholm, Sweden

[6] Tibotec BVBA, Mechelen, Belgium

[7] Tibotec Inc, Yardley, PA USA

来源：

关键词：

D O I：

10.1016/S0168-8278(09)60052-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S22 / S22

页数：1